Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 32NETWORK 3OTHER_GOV 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 2Hypertension 1Diabetes Mellitus 1

Interventions

Oxaliplatin 30Capecitabine 26Fluorouracil 20Irinotecan 19tislelizumab 18apatinib 16Paclitaxel 13Cisplatin 13S 1 (combination) 12Radiotherapy 12Leucovorin 11Bevacizumab 11Laparoscopy 9Drug Therapy 9Cetuximab 9sintilimab 8Endoscopic Mucosal Resection 8Radiation 7Gemcitabine 7Docetaxel 7camrelizumab 6XELOX 6Surgical Procedures, Operative 6Propranolol 6Nivolumab 6Neoadjuvant Therapy 6Immune Checkpoint Inhibitors 6Folfox protocol 6Levoleucovorin 5HMPL-013 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Gastrectomy × Gastrointestinal × Clear all
NCT05075421 2022-03-18

Prognostic Values of Inflammation-based Indices in Gastric Cancer

Gulhane Training and Research Hospital

Completed
350 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01643811 2016-03-24

Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients

National Cancer Center, Korea

Completed
159 enrolled
Gastrointestinal

Diabetes Mellitus, Hypertension, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡